The localization of DARPP‐32, a dopamine and cAMP‐regulated phosphoprotein, has been studied in monkey brain by immunocytochemistry. This study indicates that DARPP‐32 is enriched in neurons in regions receiving a dense dopamine input from the substantia nigra and ventral tegmental area. Thus, the majority of somata in the anterior olfactory area, nucleus accumbens, caudate nucleus, and putamen are immunoreactive for DARPP‐32. In the caudate nucleus, immunoreactive spines receive asymmetric contacts from unlabeled axon terminals. Immunoreactive somata have diameters of 10–15 μm. In regions known to receive projections from these nuclei, immunoreactivity is confined to small puncta that represent axons and axon terminals. Regions in which immunoreactivity is present in puncta include the ventral pallidum, globus pallidus, and substantia nigra pars reticulata. Dopaminergic neurons themselves are not immunoreactive.

Neurons containing moderate to weak immunoreactivity for DARPP‐32 are observed in portions of the cerebral cortex, particularly in the temporal cortex (layer VI). DARPP‐32‐positive neurons are also present in the cerebellum, in the medial habenula, and in portions of the bed nucleus of the stria terminalis and amygdaloid complex. DARPP‐32 immunoreactivity is also present in astrocytes in the subcortical white matter and in tanycytes in the arcuate nucleus and median eminence.

DARPP‐32 may be an effective marker for dopaminoceptive neurons in which the actions of dopamine on the D‐1 dopamine receptor are mediated through cAMP and its associated protein kinase. © 1992 Wiley‐Liss, Inc.